Explanatory review on pyrimidine/fused pyrimidine derivatives as anticancer agents targeting Src kinase

References

• Altmann, E., Missbach, J., Green, M., Šuša, M., Wagenknecht, H.-A., & Widler, L., (2001). 7-Pyrrolidinyl-and 7-piperidinyl-5-aryl-pyrrolo [2, 3-d] pyrimidines—potent inhibitors of the tyrosine kinase c-Src. Bioorganic & Medicinal Chemistry Letters, 11(6), 853–856. https://doi.org/10.1016/s0960-894x(01)00080-4
   PubMed Web of Science ®Google Scholar
• Arafa, R. K., Nour, M. S., & El-Sayed, N. A. (2013). Novel heterocyclic-fused pyrimidine derivatives: Synthesis, molecular modeling and pharmacological screening. European Journal of Medicinal Chemistry, 69, 498–507. https://doi.org/10.1016/j.ejmech.2013.08.042
   PubMed Web of Science ®Google Scholar
• Archna, P., Chawla, A., Teli, G., Pathania, S., Singh, S., & Srivastava, V. (2023). Exploration of antioxidant, anti-inflammatory and anticancer potential of substituted 4-thiazolidinone derivatives: Synthesis, biological evaluation and docking studies. Polycyclic Aromat. Compd. (2022), 43(1), 597–618. https://doi.org/10.1080/10406638.2021.2019796
   Web of Science ®Google Scholar
• Barlaam, B., Fennell, M., Germain, H., Green, T., Hennequin, L., Morgentin, R., Olivier, A., Plé, P., Vautier, M., & Costello, G. (2005). New heterocyclic analogues of 4-(2-chloro-5-methoxyanilino) quinazolines as potent and selective c-Src kinase inhibitors. Bioorganic & Medicinal Chemistry Letters, 15(24), 5446–5449. https://doi.org/10.1016/j.bmcl.2005.08.106
   PubMed Web of Science ®Google Scholar
• Barthakur, M. G., Borthakur, M., Devi, P., Saikia, C. J., Saikia, A., Bora, U., Chetia, A., & Boruah, R. C. (2007). A novel and efficient lewis acid catalysed preparation of pyrimidines: Microwave-promoted reaction of urea and β-formyl enamides. Synlett, 2007(02), 0223–0226.
   Google Scholar
• Bishop, J. M. (1983). Cellular oncogenes and retroviruses. Annual Review of Biochemistry, 52(1), 301–354. https://doi.org/10.1146/annurev.bi.52.070183.001505
   PubMedGoogle Scholar
• Bolen, J. B., Veillette, A., Schwartz, A. M., DeSeau, V., & Rosen, N. (1987). Activation of pp60c-src protein kinase activity in human colon carcinoma. Proceedings of the National Academy of Sciences of the United States of America, 84(8), 2251–2255. https://doi.org/10.1073/pnas.84.8.2251
   PubMed Web of Science ®Google Scholar
• Brandvold, K. R., Steffey, M. E., Fox, C. C., & Soellner, M. B. (2012). Development of a highly selective c-Src kinase inhibitor. ACS Chemical Biology, 7(8), 1393–1398. https://doi.org/10.1021/cb300172e
   PubMed Web of Science ®Google Scholar
• Brown, M. T., & Cooper, J. A. (1996). Regulation, substrates and functions of src. Biochimica et Biophysica Acta, 1287(2-3), 121–149. https://doi.org/10.1016/0304-419x(96)00003-0
   PubMed Web of Science ®Google Scholar
• Cai, J., Sun, M., Wu, X., Chen, J., Wang, P., Zong, X., & Ji, M. (2013). Design and synthesis of novel 4-benzothiazole amino quinazolines Dasatinib derivatives as potential anti-tumor agents. European Journal of Medicinal Chemistry. 63, 702–712. https://doi.org/10.1016/j.ejmech.2013.03.013
   PubMed Web of Science ®Google Scholar
• Cartwright, C., Kamps, M., Meisler, A., Pipas, J., & Eckhart, W. (1989). pp60c-src activation in human colon carcinoma. The Journal of Clinical Investigation, 83(6), 2025–2033. https://doi.org/10.1172/JCI114113
   PubMed Web of Science ®Google Scholar
• Chhikara, B. S., Ashraf, S., Mozaffari, S., St. Jeans, N., Mandal, D., Tiwari, R. K., Ul-Haq, Z., & Parang, K. (2020). Phenylpyrazalopyrimidines as tyrosine kinase inhibitors: Synthesis. Antiproliferative Activity, and Molecular Simulations, Molecules, 25(9), 2135.,
   Google Scholar
• Chu, X.-Q., Cao, W.-B., Xu, X.-P., & Ji, S.-J. (2017). Iron catalysis for modular pyrimidine synthesis through β-ammoniation/cyclization of saturated carbonyl compounds with amidines. The Journal of Organic Chemistry, 82(2), 1145–1154. https://doi.org/10.1021/acs.joc.6b02767
   PubMed Web of Science ®Google Scholar
• Cui, Z., Chen, S., Wang, Y., Gao, C., Chen, Y., Tan, C., & Jiang, Y. (2017). Design, synthesis and evaluation of azaacridine derivatives as dual-target EGFR and Src kinase inhibitors for antitumor treatment. European Journal of Medicinal Chemistry, 136, 372–381. https://doi.org/10.1016/j.ejmech.2017.05.006
   PubMed Web of Science ®Google Scholar
• Du, G., Rao, S., Gurbani, D., Henning, N. J., Jiang, J., Che, J., Yang, A., Ficarro, S. B., Marto, J. A., Aguirre, A. J., Sorger, P. K., Westover, K. D., Zhang, T., & Gray, N. S. (2020). Structure-based design of a potent and selective covalent inhibitor for SRC kinase that targets a P-loop cysteine. Journal of Medicinal Chemistry, 63(4), 1624–1641. https://doi.org/10.1021/acs.jmedchem.9b01502
   PubMed Web of Science ®Google Scholar
• Fang, F., Li, D.-D., Li, J.-R., Sun, J., Du, Q.-R., Gong, H.-B., & Zhu, H.-L. (2013). Design, synthesis, and evaluation of substituted 6-amide-4-anilinoquinazoline derivatives as c-Src inhibitors. RSC Advances, 3(48), 26230–26240. https://doi.org/10.1039/c3ra45204b
   Web of Science ®Google Scholar
• Fraser, C., Dawson, J. C., Dowling, R., Houston, D. R., Weiss, J. T., Munro, A. F., Muir, M., Harrington, L., Webster, S. P., Frame, M. C., Brunton, V. G., Patton, E. E., Carragher, N. O., & Unciti-Broceta, A. (2016). Rapid discovery and structure–activity relationships of pyrazolopyrimidines that potently suppress breast cancer cell growth via SRC kinase inhibition with exceptional selectivity over ABL kinase. Journal of Medicinal Chemistry, 59(10), 4697–4710. https://doi.org/10.1021/acs.jmedchem.6b00065
   PubMed Web of Science ®Google Scholar
• Gayon, E., Szymczyk, M., Gérard, H., Vrancken, E., & Campagne, J.-M. (2012). Stereoselective and catalytic access to β-enaminones: An entry to pyrimidines. The Journal of Organic Chemistry, 77(20), 9205–9220. https://doi.org/10.1021/jo301675g
   PubMed Web of Science ®Google Scholar
• Guarino, M. (2010). Src signaling in cancer invasion. Journal of Cellular Physiology, 223(1), 14–26. https://doi.org/10.1002/jcp.22011
   PubMed Web of Science ®Google Scholar
• Guo, W., Li, C., Liao, J., Ji, F., Liu, D., Wu, W., & Jiang, H. (2016). Transition metal free intermolecular direct oxidative C–N bond formation to polysubstituted pyrimidines using molecular oxygen as the sole oxidant. The Journal of Organic Chemistry, 81(13), 5538–5546. https://doi.org/10.1021/acs.joc.6b00867
   PubMed Web of Science ®Google Scholar
• Henidi, H. A., Al-Abd, A. M., Al-Abbasi, F. A., BinMahfouz, H. A., & El-Deeb, I. M. (2019). Design and synthesis of novel phenylaminopyrimidines with antiproliferative activity against colorectal cancer. RSC Advances, 9(37), 21578–21586. https://doi.org/10.1039/c9ra03359a
   PubMed Web of Science ®Google Scholar
• Hennequin, L. F., Allen, J., Breed, J., Curwen, J., Fennell, M., Green, T. P., Lambert-van der Brempt, C., Morgentin, R., Norman, R. A., Olivier, A., Otterbein, L., Plé, P. A., Warin, N., & Costello, G. (2006). N-(5-Chloro-1, 3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl) ethoxy]-5-(tetrahydro-2 H-pyran-4-yloxy) quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src/Abl kinase inhibitor. Journal of Medicinal Chemistry, 49(22), 6465–6488. https://doi.org/10.1021/jm060434q
   PubMed Web of Science ®Google Scholar
• Hu, G., Place, A. T., & Minshall, R. D. (2008). Regulation of endothelial permeability by Src kinase signaling: Vascular leakage versus transcellular transport of drugs and macromolecules. Chemico-Biological Interactions, 171(2), 177–189. https://doi.org/10.1016/j.cbi.2007.08.006
   PubMed Web of Science ®Google Scholar
• Huang, H., Ma, J., Shi, J., Meng, L., Jiang, H., Ding, J., & Liu, H. (2010). Discovery of novel purine derivatives with potent and selective inhibitory activity against c-Src tyrosine kinase. Bioorganic & Medicinal Chemistry, 18(13), 4615–4624. https://doi.org/10.1016/j.bmc.2010.05.032
   PubMed Web of Science ®Google Scholar
• Huang, W.-S., Zhu, X., Wang, Y., Azam, M., Wen, D., Sundaramoorthi, R., Thomas, R. M., Liu, S., Banda, G., Lentini, S. P., Das, S., Xu, Q., Keats, J., Wang, F., Wardwell, S., Ning, Y., Snodgrass, J. T., Broudy, M. I., Russian, K., … Shakespeare, W. C. (2009). 9-(Arenethenyl) purines as dual Src/Abl kinase inhibitors targeting the inactive conformation: Design, synthesis, and biological evaluation. Journal of Medicinal Chemistry, 52(15), 4743–4756. https://doi.org/10.1021/jm900166t
   PubMed Web of Science ®Google Scholar
• Hubbard, S. R., & Till, J. H. (2000). Protein tyrosine kinase structure and function. Annual Review of Biochemistry, 69(1), 373–398. https://doi.org/10.1146/annurev.biochem.69.1.373
   PubMed Web of Science ®Google Scholar
• Irby, R. B., Mao, W., Coppola, D., Kang, J., Loubeau, J. M., Trudeau, W., Karl, R., Fujita, D. J., Jove, R., & Yeatman, T. J. (1999). Activating SRC mutation in a subset of advanced human colon cancers. Nature Genetics, 21(2), 187–190. https://doi.org/10.1038/5971
   PubMed Web of Science ®Google Scholar
• Jadhav, S. D., & Singh, A. (2017). Oxidative annulations involving DMSO and formamide: K2S2O8 mediated syntheses of quinolines and pyrimidines. Organic Letters, 19(20), 5673–5676. https://doi.org/10.1021/acs.orglett.7b02838
   PubMed Web of Science ®Google Scholar
• Jain, K., Chitre, T., Miniyar, P., Kathiravan, M., Bendre, V., Veer, V., Shahane, S., & Shishoo, C. (2006). Biological and medicinal significance of pyrimidines, Curr. Sci, 793–803.
   Web of Science ®Google Scholar
• Joule, J. A., Mills, K., & Smith, G. F. (2020). Heterocyclic chemistry. CRC Press.
   Google Scholar
• Kaplan, J., Mardon, G., Bishop, J., & Varmus, H. (1988). The first seven amino acids encoded by the v-Src oncogene act as a myristylation signal: Lysine 7 is a critical determinant. Molecular and Cellular Biology, 8(6), 2435–2441. https://doi.org/10.1128/MCB.8.6.2435
   PubMed Web of Science ®Google Scholar
• Kappe, C. O. (1993). 100 years of the Biginelli dihydropyrimidine synthesis. Tetrahedron, 49(32), 6937–6963.
   Web of Science ®Google Scholar
• Liu, F., Zhang, X., Qian, Q., & Yang, C. (2020). A concise and efficient approach to 2, 6-disubstituted 4-fluoropyrimidines from α-CF3 aryl ketones. Synthesis, 52(02), 273–280. https://doi.org/10.1055/s-0039-1690248
   Google Scholar
• Lombardo, L. J., Lee, F. Y., Chen, P., Norris, D., Barrish, J. C., Behnia, K., Castaneda, S., Cornelius, L. A. M., Das, J., Doweyko, A. M., Fairchild, C., Hunt, J. T., Inigo, I., Johnston, K., Kamath, A., Kan, D., Klei, H., Marathe, P., Pang, S., … Borzilleri, R. M. (2004). Discovery of N-(2-chloro-6-methyl-phenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin-4-ylamino) thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays. Journal of Medicinal Chemistry, 47(27), 6658–6661. https://doi.org/10.1021/jm049486a
   PubMed Web of Science ®Google Scholar
• Lu, X.-L., Liu, X.-Y., Cao, X., & Jiao, B.-H. (2012). Novel patented SRC kinase inhibitor. Current Medicinal Chemistry, 19(12), 1821–1829. https://doi.org/10.2174/092986712800099802
   PubMed Web of Science ®Google Scholar
• Luo, J., Zou, H., Guo, Y., Tong, T., Ye, L., Zhu, C., Deng, L., Wang, B., Pan, Y., & Li, P. (2022). SRC kinase-mediated signaling pathways and targeted therapies in breast cancer. Breast Cancer Research, 24(1), 1–17. https://doi.org/10.1186/s13058-022-01596-y
   PubMed Web of Science ®Google Scholar
• Ma, Y.-C., & Huang, X.-Y. (2002). Novel regulation and function of Src tyrosine kinase. Cellular and Molecular Life Sciences CMLS, 59(3), 456–462. https://doi.org/10.1007/s00018-002-8438-2
   PubMed Web of Science ®Google Scholar
• Malki, W. H., Gouda, A. M., Ali, H. E., Al-Rousan, R., Samaha, D., Abdalla, A. N., Bustamante, J., Abd Elmageed, Z. Y., & Ali, H. I. (2018). Structural-based design, synthesis, and antitumor activity of novel alloxazine analogues with potential selective kinase inhibition. European Journal of Medicinal Chemistry, 152, 31–52. https://doi.org/10.1016/j.ejmech.2018.04.029
   PubMed Web of Science ®Google Scholar
• Manchanda, P., Parshad, B., Kumar, A., Tiwari, R. K., Shirazi, A. N., Parang, K., & Sharma, S. K. (2017). Design, synthesis, and evaluation of the kinase inhibition potential of pyridylpyrimidinylaminophenyl derivatives. Archiv Der Pharmazie, 350(3-4), 1600390. https://doi.org/10.1002/ardp.201600390
   Web of Science ®Google Scholar
• Mao, W., Irby, R., Coppola, D., Fu, L., Wloch, M., Turner, J., Yu, H., Garcia, R., Jove, R., & Yeatman, T. J. (1997). Activation of c-Src by receptor tyrosine kinases in human colon cancer cells with high metastatic potential. Oncogene, 15(25), 3083–3090. https://doi.org/10.1038/sj.onc.1201496
   PubMed Web of Science ®Google Scholar
• Mehta, D., & Malik, A. B. (2006). Signaling mechanisms regulating endothelial permeability. Physiol, 86(1), 279–367. https://doi.org/10.1152/physrev.00012.2005
   Google Scholar
• Musumeci, F., Fallacara, A. L., Brullo, C., Grossi, G., Botta, L., Calandro, P., Chiariello, M., Kissova, M., Crespan, E., Maga, G., & Schenone, S. (2017). Identification of new pyrrolo [2, 3-d] pyrimidines as Src tyrosine kinase inhibitors in vitro active against Glioblastoma. European Journal of Medicinal Chemistry, 127, 369–378. https://doi.org/10.1016/j.ejmech.2016.12.036
   PubMed Web of Science ®Google Scholar
• Negi, P., Cheke, R. S., & Patil, V. M. (2021). Recent advances in pharmacological diversification of Src family kinase inhibitors. Egyptian Journal of Medical Human Genetics, 22(1), 1–16. https://doi.org/10.1186/s43042-021-00172-x
   Google Scholar
• Pal, R., Kumar, B., Swamy P M, G., & Chawla, P. A. (2023). Design, synthesis of 1, 2, 4-triazine derivatives as antidepressant and antioxidant agents: In vitro, in vivo and in silico studies. Bioorganic Chemistry, 131, 106284. https://doi.org/10.1016/j.bioorg.2022.106284
   PubMed Web of Science ®Google Scholar
• Perera, B. G. K., & Maly, D. J. (2008). Design, synthesis and characterization of “clickable” 4-anilinoquinazoline kinase inhibitors. Molecular bioSystems, 4(6), 542–550. https://doi.org/10.1039/b720014e
   PubMedGoogle Scholar
• Ple, P. A., Green, T. P., Hennequin, L. F., Curwen, J., Fennell, M., Allen, J., Lambert-Van Der Brempt, C., & Costello, G. (2004). Discovery of a new class of anilinoquinazoline inhibitors with high affinity and specificity for the tyrosine kinase domain of c-Src. Journal of Medicinal Chemistry, 47(4), 871–887. https://doi.org/10.1021/jm030317k
   PubMed Web of Science ®Google Scholar
• Rosen, N., Bolen, J., Schwartz, A., Cohen, P., DeSeau, V., & Israel, M. (1986). Analysis of pp60c-src protein kinase activity in human tumor cell lines and tissues. The Journal of Biological Chemistry, 261(29), 13754–13759. https://doi.org/10.1016/S0021-9258(18)67084-X
   PubMed Web of Science ®Google Scholar
• Roskoski, R. Jr, (2015). Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors. Pharmacological Research, 94, 9–25. https://doi.org/10.1016/j.phrs.2015.01.003
   PubMed Web of Science ®Google Scholar
• Sasada, T., Kobayashi, F., Sakai, N., & Konakahara, T. (2009). An unprecedented approach to 4, 5-disubstituted pyrimidine derivatives by a ZnCl2-catalyzed three-component coupling reaction. Organic Letters, 11(10), 2161–2164. https://doi.org/10.1021/ol900382j
   PubMed Web of Science ®Google Scholar
• Schlessinger, J. (2000). New roles for Src kinases in control of cell survival and angiogenesis. Cell, 100(3), 293–296. https://doi.org/10.1016/S0092-8674(00)80664-9
   PubMed Web of Science ®Google Scholar
• Schöning-Stierand, K., Diedrich, K., Fährrolfes, R., Flachsenberg, F., Meyder, A., Nittinger, E., Steinegger, R., & Rarey, M. (2020). Proteins Plus: Interactive analysis of protein–ligand binding interfaces. Nucleic Acids Research, 48(W1), W48–W53. https://doi.org/10.1093/nar/gkaa235
   PubMed Web of Science ®Google Scholar
• Sharma, V., Chitranshi, N., & Agarwal, A. K. (2014). Significance and biological importance of pyrimidine in the microbial world. International Journal of Medicinal Chemistry, 2014, 1–31. (). https://doi.org/10.1155/2014/202784
   Google Scholar
• Su, L., Sun, K., Pan, N., Liu, L., Sun, M., Dong, J., Zhou, Y., & Yin, S.-F. (2018). Cyclization of ketones with nitriles under base: A general and economical synthesis of pyrimidines. Organic Letters, 20(11), 3399–3402. https://doi.org/10.1021/acs.orglett.8b01324
   PubMed Web of Science ®Google Scholar
• Teli, G., & Chawla, P. A. (2021). Hybridization of imidazole with various heterocycles in targeting cancer: A decade’s work. Chemistry Select, 6(19), 4803–4836. https://doi.org/10.1002/slct.202101038
   Google Scholar
• Thomas, S. M., & Brugge, J. S. (1997). Cellular functions regulated by Src family kinases. Annual Review of Cell and Developmental Biology, 13, 513–609. https://doi.org/10.1146/annurev.cellbio.13.1.513
   PubMed Web of Science ®Google Scholar
• Tintori, C., Fallacara, A. L., Radi, M., Zamperini, C., Dreassi, E., Crespan, E., Maga, G., Schenone, S., Musumeci, F., Brullo, C., Richters, A., Gasparrini, F., Angelucci, A., Festuccia, C., Delle Monache, S., Rauh, D., & Botta, M. (2015). Combining X-ray crystallography and molecular modeling toward the optimization of pyrazolo [3, 4-d] pyrimidines as potent c-Src inhibitors active in vivo against neuroblastoma. Journal of Medicinal Chemistry, 58(1), 347–361. https://doi.org/10.1021/jm5013159
   PubMed Web of Science ®Google Scholar
• Tiwari, R. K., Brown, A., Sadeghiani, N., Shirazi, A. N., Bolton, J., Tse, A., Verkhivker, G., Parang, K., & Sun, G. (2017). Design, synthesis, and evaluation of dasatinib–amino acid and dasatinib–fatty acid conjugates as protein tyrosine kinase inhibitors. Chem Med Chem, 12(1), 86–99. https://doi.org/10.1002/cmdc.201600387
   Google Scholar
• Volkamer, A., Griewel, A., Grombacher, T., & Rarey, M. (2010). Analyzing the topology of active sites: On the prediction of pockets and subpockets. Journal of Chemical Information and Modeling, 50(11), 2041–2052. https://doi.org/10.1021/ci100241y
   PubMed Web of Science ®Google Scholar
• Volkamer, A., Kuhn, D., Grombacher, T., Rippmann, F., & Rarey, M. (2012). Combining global and local measures for structure-based druggability predictions. Journal of Chemical Information and Modeling, 52(2), 360–372. https://doi.org/10.1021/ci200454v
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2015). Cancer. http://www.who.int/cancer/en/
   Google Scholar
• Xu, W., Doshi, A., Lei, M., Eck, M. J., & Harrison, S. C. (1999). Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Mol. Cell, 3(5), 629–638. https://doi.org/10.1016/S1097-2765(00)80356-1
   PubMed Web of Science ®Google Scholar
• Yang, K., Dang, Q., Cai, P.-J., Gao, Y., Yu, Z.-X., & Bai, X. (2017). Reaction of aldehydes/ketones with electron-deficient 1, 3, 5-triazines leading to functionalized pyrimidines as diels–alder/retro-diels–alder reaction products: Reaction development and mechanistic studies. The Journal of Organic Chemistry, 82(5), 2336–2344. https://doi.org/10.1021/acs.joc.6b02570
   PubMed Web of Science ®Google Scholar
• Zhang, C.-H., Zheng, M.-W., Li, Y.-P., Lin, X.-D., Huang, M., Zhong, L., Li, G.-B., Zhang, R.-J., Lin, W.-T., Jiao, Y., Wu, X.-A., Yang, J., Xiang, R., Chen, L.-J., Zhao, Y.-L., Cheng, W., Wei, Y.-Q., & Yang, S.-Y. (2015). Design, synthesis, and structure–activity relationship studies of 3-(Phenylethynyl)-1 H-pyrazolo [3, 4-d] pyrimidin-4-amine derivatives as a new class of Src inhibitors with potent activities in models of triple negative breast cancer. Journal of Medicinal Chemistry, 58(9), 3957–3974. https://doi.org/10.1021/acs.jmedchem.5b00270
   PubMed Web of Science ®Google Scholar